Cargando…

TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease

Detalles Bibliográficos
Autores principales: Bangma, Amber, Voskuil, Michiel D., Weersma, Rinse K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834454/
https://www.ncbi.nlm.nih.gov/pubmed/32553760
http://dx.doi.org/10.1053/j.gastro.2020.05.091
_version_ 1783642284385894400
author Bangma, Amber
Voskuil, Michiel D.
Weersma, Rinse K.
author_facet Bangma, Amber
Voskuil, Michiel D.
Weersma, Rinse K.
author_sort Bangma, Amber
collection PubMed
description
format Online
Article
Text
id pubmed-7834454
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher by the AGA Institute
record_format MEDLINE/PubMed
spelling pubmed-78344542021-01-26 TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease Bangma, Amber Voskuil, Michiel D. Weersma, Rinse K. Gastroenterology Correspondence by the AGA Institute 2021-06 2020-06-15 /pmc/articles/PMC7834454/ /pubmed/32553760 http://dx.doi.org/10.1053/j.gastro.2020.05.091 Text en © 2020 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Bangma, Amber
Voskuil, Michiel D.
Weersma, Rinse K.
TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease
title TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease
title_full TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease
title_fullStr TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease
title_full_unstemmed TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease
title_short TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease
title_sort tnfα-antagonist use and mucosal inflammation are associated with increased intestinal expression of sars-cov-2 host protease tmprss2 in patients with inflammatory bowel disease
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834454/
https://www.ncbi.nlm.nih.gov/pubmed/32553760
http://dx.doi.org/10.1053/j.gastro.2020.05.091
work_keys_str_mv AT bangmaamber tnfaantagonistuseandmucosalinflammationareassociatedwithincreasedintestinalexpressionofsarscov2hostproteasetmprss2inpatientswithinflammatoryboweldisease
AT voskuilmichield tnfaantagonistuseandmucosalinflammationareassociatedwithincreasedintestinalexpressionofsarscov2hostproteasetmprss2inpatientswithinflammatoryboweldisease
AT weersmarinsek tnfaantagonistuseandmucosalinflammationareassociatedwithincreasedintestinalexpressionofsarscov2hostproteasetmprss2inpatientswithinflammatoryboweldisease